You just read:

Efficacy and Safety Data from Phase 2B Trials of Janssen's Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases

News provided by

Janssen Pharmaceuticals, Inc.

10 Nov, 2012, 14:00 GMT